COX-2 expression during early lung squamous cell carcinoma oncogenesis. C. Mascaux, B. Martin, J-M. Verdebout, V. Ninane and J-P. Sculier. Eur Respir J 2005; 26: 198-203.


Source: Eur Respir J 2005; 26: 753
Journal Issue: October
Disease area: Thoracic oncology

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
COX-2 expression during early lung squamous cell carcinoma oncogenesis. C. Mascaux, B. Martin, J-M. Verdebout, V. Ninane and J-P. Sculier. Eur Respir J 2005; 26: 198-203.. Eur Respir J 2005; 26: 753

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
“Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma.” M. Ramael, J. Nagels, H. Heylen, S. De Schepper, J. Paulussen, M. De Maeyer and C. Van Haesendonck. Eur Respir J 1999; 14: 1381–1386.
Source: Eur Respir J, 55 (5) 9951381; 10.1183/13993003.51381-1999
Year: 2020


“Mast cells promote lung vascular remodelling in pulmonary hypertension.” J. Hoffmann, J. Yin, M. Kukucka, N. Yin, I. Saarikko, A. Sterner-Kock, H. Fujii, H. Leong-Poi, H. Kuppe, R.T. Schermuly and W.M. Kuebler. Eur Respir J 2011; 37: 1400–1410.
Source: Eur Respir J 2012; 40: 515-517
Year: 2012


"No evidence for interstitial lung oedema by extensive pulmonary function testing at 4,559". C. Dehnert, A.M. Luks, G. Schendler, E. Menold, M.M. Berger, H. Mairbäurl, V. Faoro, D.M. Bailey, C. Castell, G. Hahn, P. Vock, E.R. Swenson and P. Bärtsch. Eur Respir J 2010; 35: 812-820.
Source: Eur Respir J 2010; 36: 699
Year: 2010



“Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.” A.U. Wells, J. Behr, U. Costabel, V. Cottin and V. Poletti. Eur Respir J 2012; 39: 805–806.
Source: Eur Respir J 2012; 39: 1552
Year: 2012


“Intersections of lung progenitor cells, lung disease and lung cancer.” Carla F. Kim. Eur Respir Rev 2017; 26: 170054.
Source: Eur Respir Rev, 26 (146) 175054; 10.1183/16000617.5054-2017
Year: 2017


Author Correction: “Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-?B and EGFR pathways.” C.A. Hewson, J.J. Haas, N.W. Bartlett, S.D. Message, V. Laza-Stanca, T. Kebadze, G. Caramori, J. Zhu, M.R. Edbrooke, L.A. Stanciu, O.M. Kon, A. Papi, P.K. Jeffery, M.R. Edwards and S.L. Johnston. Eur Respir J 2010; 36: 1425–1435.
Source: Eur Respir J 2012; 39: 793
Year: 2012


“Cellular mechanisms underlying steroid-resistant asthma.” Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro. Eur Respir Rev 2019; 28: 190021.
Source: Eur Respir Rev, 28 (154) 195096; 10.1183/16000617.5096-2019
Year: 2019


“Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.” M. Wilschanski, L.L. Miller, D. Shoseyov, H. Blau, J. Rivlin, M. Aviram, M. Cohen, S. Armoni, Y. Yaakov, T. Pugatch, M. Cohen-Cymberknoh, N.L. Miller, A. Reha, V.J. Northcutt, S. Hirawat, K. Donnelly, G.L. Elfring, T. Ajayi and E. Kerem. Eur Respir J 2011; 38: 59–69.
Source: Eur Respir J 2011; 38: 996
Year: 2011


“Effect of different asthma treatments on risk of cold-related exacerbations.” H.K. Reddel, C. Jenkins, S. Quirce, M.R. Sears, E.D. Bateman, P.M. O'Byrne, M. Humbert, R. Buhl, T. Harrison, G.G. Brusselle, A. Thorén, U. Sjöbring, S. Peterson, O. Östlund and G.S. Eriksson. Eur Respir J 2011; 38: 584–593.
Source: Eur Respir J 2012; 39: 1280
Year: 2012


“Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias.” M. Okamoto, T. Hoshino, Y. Kitasato, Y. Sakazaki, T. Kawayama, K. Fujimoto, K. Ohshima, H. Shiraishi, M. Uchida, J. Ono, S. Ohta, S. Kato, K. Izuhara and H. Aizawa. Eur Respir J 2011; 37: 1119–1127.
Source: Eur Respir J 2014; 44: 826
Year: 2014


Author Correction: “Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis.” M. Sester, G. Sotgiu, C. Lange, C. Giehl, E. Girardi, G.B. Migliori, A. Bossink, K. Dheda, R. Diel, J. Dominguez, M. Lipman, J. Nemeth, P. Ravn, S. Winkler, E. Huitric, A. Sandgren and D. Manissero. Eur Respir J 2011; 37: 100–111.
Source: Eur Respir J 2012; 39: 793
Year: 2012


“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784.
Source: Eur Respir J 2016; 48: 593
Year: 2016


“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647.
Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019
Year: 2020



“Sleep apnoea is associated with major cardiac events in peripheral arterial disease.” Karri T. Utriainen, Juhani K. Airaksinen, Olli Polo, Ruut Laitio, Mikko J. Pietilä, Harry Scheinin, Tero Vahlberg, Kari A. Leino, Erkki S. Kentala, Jouko R. Jalonen, Harri Hakovirta, Riitta Parkkola, Sami Virtanen and Timo T. Laitio. Eur Respir J 2014; 43: 1652-1660.
Source: Eur Respir J, 51 (4) 1351309; 10.1183/13993003.51309-2013
Year: 2018


“A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice.” Akihiro Takemasa, Yoshiki Ishii and Takeshi Fukuda. Eur Respir J 2012; 40: 1475–1482.
Source: Eur Respir J 2014; 44: 1101
Year: 2014


“Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.” Yael Gernez, Jeffrey Waters, Bojana Mirkovic, Gillian M. Lavelle, Colleen E. Dunn, Zoe A. Davies, Cassie Everson, Rabindra Tirouvanziam, Elana Silver, Sylvan Wallenstein, Sanjay H. Chotirmall, Noel G. McElvaney, Leonore A. Herzenberg and Richard B. Moss. Eur Respir J 2016; 47: 177–185.
Source: Eur Respir J 2016; 47:1892
Year: 2016


“The role of nebulised budesonide in the treatment of exacerbations of COPD.” H. Gunen, S.S. Hacievliyagil, O. Yetkin, G. Gulbas, L.C. Mutlu and E. In. Eur Respir J 2007; 29: 660–667.
Source: Eur Respir J 2014; 44: 272
Year: 2014


“Characterisation of patients with interstitial pneumonia with autoimmune features.” Justin M. Oldham, Ayodeji Adegunsoye, Eleanor Valenzi, Cathryn Lee, Leah Witt, Lena Chen, Aliya N. Husain, Steven Montner, Jonathan H. Chung, Vincent Cottin, Aryeh Fischer, Imre Noth, Rekha Vij and Mary E. Strek. Eur Respir J 2016; 47: 1767–1775.
Source: Eur Respir J, 49 (5) 1551565; 10.1183/13993003.51565-2015
Year: 2017


“Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis.” Yuan Zhang, Nan Li, Yuxuan Zhang, Huiping Li, Xueyuan Chen, Shanmei Wang, Xia Zhang, Rongxuan Zhang, Jinfu Xu, Jingyun Shi and Rex C. Yung. Eur Respir J 2012; 40: 1191–1200.
Source: Eur Respir J 2013; 41: 252
Year: 2013


“Health consequences associated with frequent wheezing in adolescents without asthma diagnosis.” K. Yeatts, K. Johnston Davis, D. Peden and C. Shy. Eur Respir J 2003; 22: 781–786.
Source: Eur Respir J 2015; 46: 1532
Year: 2015